EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent

Xu Hou iD, Taylor Hsuan-Yu Chen, Shunsuke Koga iD, Jenny M Bredenberg, Ayman H Faroqi, Marion Delenclos, Guojun Bu, Zbigniew K Wszolek, Jonathan A Carr, Owen A Ross, Pamela J McLean, Melissa E Murray und 3 weitere

Brain Pathology · 2023

DOI: 10.1111/bpa.13175 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Pathology, 2023. Verfasst von Xu Hou und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA. Hauptthemen laut MEDLINE: alpha-Synuclein, Parkinson Disease. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIA NIH HHS, Alzheimer's Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alpha‐synuclein (αsyn) aggregates are pathological features of several neurodegenerative conditions including Parkinson disease (PD), dementia with Lewy bodies, and multiple system atrophy (MSA). Accumulating evidence suggests that mitochondrial dysfunction and impairments of the autophagic‐lysosomal system can contribute to the deposition of αsyn, which in turn may interfere with health and function of these organelles in a potentially vicious cycle. Here we investigated a potential convergence of αsyn with the PINK1‐PRKN‐mediated mitochondrial autophagy pathway in cell models, αsyn transgenic mice, and human autopsy brain. PINK1 and PRKN identify and selectively label damaged mitochondria with phosphorylated ubiquitin (pS65‐Ub) to mark them for degradation (mitophagy). We found that disease‐causing multiplications of αsyn resulted in accumulation of the ubiquitin ligase PRKN in cells. This effect could be normalized by starvation‐induced autophagy activation and by CRISPR/Cas9‐mediated αsyn knockout. Upon acute mitochondrial damage, the increased levels of PRKN protein contributed to an enhanced pS65‐Ub response. We further confirmed increased pS65‐Ub‐immunopositive signals in mouse brain with αsyn overexpression and in postmortem human disease brain. Of note, increased pS65‐Ub was associated with neuronal Lewy body‐type αsyn pathology, but not glial cytoplasmic inclusions of αsyn as seen in MSA. While our results add another layer of complexity to the crosstalk between αsyn and the PINK1‐PRKN pathway, distinct mechanisms may underlie in cells and brain tissue despite similar outcomes. Notwithstanding, our finding suggests that pS65‐Ub may be useful as a biomarker to discriminate different synucleinopathies and may serve as a potential therapeutic target for Lewy body disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

alpha-SynucleinParkinson DiseaseAnimalsHumansMiceMice, TransgenicMitophagyProtein KinasesUbiquitinUbiquitin-Protein LigasesPTEN-Induced Putative Kinase

Stichwörter der Autor:innen

Lewy body diseasePINK1PRKNParkinson diseasealpha-synucleinautophagymitochondriamitophagymultiple system atrophyphosphorylated ubiquitin

Substanzen

alpha-SynucleinProtein KinasesUbiquitinUbiquitin-Protein LigasesPTEN-Induced Putative Kinaseparkin proteinSnca protein, mouseSNCA protein, human

Autor:innen und Institutionen

  • Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA.
  • Neuroscience PhD Program, Mayo Clinic Graduate School of Biomedical Sciences, Jacksonville, Florida, USA.
  • Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA.
  • Division of Neurology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

ORCID-Profile: Xu Hou, Shunsuke Koga

Förderung

  • NINDS NIH HHS
  • NIA NIH HHS
  • Alzheimer's Association
  • Congressionally Directed Medical Research Programs
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Hou, X., Chen, T. H., Koga, S., Bredenberg, J. M., Faroqi, A. H., Delenclos, M., Bu, G., Wszolek, Z. K., Carr, J. A., Ross, O. A., McLean, P. J., Murray, M. E., Dickson, D. W., Fiesel, F. C., & Springer, W. (2023). Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent. Brain Pathology. https://doi.org/10.1111/bpa.13175

Vancouver

Hou X, Chen TH, Koga S, Bredenberg JM, Faroqi AH, Delenclos M, et al. Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent. Brain Pathology. 2023. doi:10.1111/bpa.13175

BibTeX
@article{Hou2023,
  author = {Hou, Xu and Chen, Taylor Hsuan-Yu and Koga, Shunsuke and Bredenberg, Jenny M and Faroqi, Ayman H and Delenclos, Marion and Bu, Guojun and Wszolek, Zbigniew K and Carr, Jonathan A and Ross, Owen A and McLean, Pamela J and Murray, Melissa E and Dickson, Dennis W and Fiesel, Fabienne C and Springer, Wolfdieter},
  title = {Alpha‐synuclein‐associated changes in PINK1‐PRKN‐mediated mitophagy are disease context dependent},
  journal = {Brain Pathology},
  year = {2023},
  doi = {10.1111/bpa.13175}
}
Kostenlos starten →